Our findings confirm that β‐Thy has the capability to influence the expression of SOD1 at both mRNA and protein levels, thereby counteracting the oncogenic effects of SOD1 on the malignant characteristics of NSCLC cells. The gene discussed is SOD1; the disease is non-small cell lung carcinoma.